Compare CURI & EDAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CURI | EDAP |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 189.5M | 163.4M |
| IPO Year | N/A | 1998 |
| Metric | CURI | EDAP |
|---|---|---|
| Price | $3.31 | $4.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | $6.00 | ★ $8.50 |
| AVG Volume (30 Days) | ★ 297.0K | 64.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 9.64% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $42.19 | N/A |
| Revenue Next Year | $7.94 | $7.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.06 | $1.21 |
| 52 Week High | $7.15 | $5.05 |
| Indicator | CURI | EDAP |
|---|---|---|
| Relative Strength Index (RSI) | 45.26 | 47.73 |
| Support Level | $3.30 | $3.89 |
| Resistance Level | $5.01 | $4.24 |
| Average True Range (ATR) | 0.14 | 0.33 |
| MACD | 0.03 | -0.08 |
| Stochastic Oscillator | 48.75 | 43.86 |
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. Its mission is to provide premium real entertainment that informs, enchants, and inspires. Its product and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, Enterprise Subscriptions and Others. The majority of the revenue comes from the Direct to direct-to-consumer business.
Edap TMS SA is a holding company operating in three divisions namely, HIFU (High-Intensity Focused Ultrasound), ESWL (Extracorporeal ShockWave Lithotripsy), and Distribution. The HIFU division develops, manufactures, and markets devices for the invasive destruction of certain types of tumors using HIFU technology. It markets three HIFU devices: the Ablatherm, Ablatherm Fusion, and the Focal One. The ESWL division is engaged in the manufacturing, marketing, and servicing of its installed base of Sonolith range of lithotripters. The Distribution division markets products that are complementary to its globalized activity such as lasers, micro-ultrasound systems, and other medical products from third parties. Its geographical segments are Asia, France, United States, and Others.